Common Contracts
2 similar Collaboration and License Agreement contracts by Exelixis, Inc.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • July 14th, 2017 • Exelixis, Inc. • Services-commercial physical & biological research • Delaware
This Collaboration and License Agreement (the “Agreement”) is entered into as of January 30, 2017 (the “Effective Date”), by and between Exelixis, Inc., a Delaware company having an address at 210 East Grand Avenue, South San Francisco, CA 94080, USA (“Exelixis”) and Takeda Pharmaceutical Company Limited, a Japanese corporation with principal offices located at 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, JAPAN (“Collaborator”). Exelixis and Collaborator may be referred to herein individually as a “Party” or collectively as the “Parties”.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 1st, 2017 • Exelixis, Inc. • Services-commercial physical & biological research • Delaware
THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 30, 2017 (the “Effective Date”), by and between EXELIXIS, INC., a Delaware company having an address at 210 East Grand Avenue, South San Francisco, CA 94080, USA (“Exelixis”) and Takeda Pharmaceutical Company Limited, a Japanese corporation with principal offices located at 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, JAPAN (“Collaborator”). Exelixis and Collaborator may be referred to herein individually as a “Party” or collectively as the “Parties”.
